D07.5 vs N42.3
D07.5 (Carcinoma in situ of prostate) compared with N42.3 (Dysplasia of prostate), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.
Can these codes be reported together?
No — do not report together. D07.5 carries an Excludes1 note covering N42.3: “dysplasia (mild) (moderate) of prostate (N42.3-)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
No — do not report together. D07.5 carries an Excludes1 note covering N42.3: “prostatic intraepithelial neoplasia II [PIN II] (N42.3-)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
Side by side
| D07.5Carcinoma in situ of prostate | N42.3Dysplasia of prostate | |
|---|---|---|
| Billing status | Billable | Non-billable header |
| Classification | C00-D49 — Neoplasms (C00-D49) | N00-N99 — Diseases of the Genitourinary System (N00-N99) |
| Definition | Carcinoma in situ of prostate is a billable ICD-10-CM diagnosis code (D07.5). | Dysplasia of prostate is a non-billable ICD-10-CM category code (N42.3). |
| Includes | Bowen's disease erythroplasia grade III intraepithelial neoplasia Queyrat's erythroplasia | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources